![Avraham Hampel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Avraham Hampel
Corporate Officer/Principal presso OPHECTRA REAL ESTATE AND INVESTMENTS LTD
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Yaron Kaiser | M | 46 | - | |
Jonathan Burgin | M | 63 |
BioCancell Therapeutics, Inc.
![]() BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 13 anni |
David Gerbi | M | 45 | 5 anni | |
Sari Singer Kaufman | F | 44 | 3 anni | |
Arik Kaufman | M | 42 | 32 anni | |
Eli Arad | M | 51 | 6 anni | |
Daniel Spira | M | 69 | 19 anni | |
Michal Gilon Ohev Zion | M | 46 |
BioCancell Therapeutics, Inc.
![]() BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 11 anni |
Ofer Goldberg | M | 52 |
BioCancell Therapeutics, Inc.
![]() BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 13 anni |
Aharon Schwartz | M | 80 |
BioCancell Therapeutics, Inc.
![]() BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | 13 anni |
Ofer Gonen | M | 50 |
BioCancell Therapeutics, Inc.
![]() BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | - |
Shmuel Levy | M | 57 | 6 anni | |
Moran Attar Yossef | F | 41 | 1 anni | |
Simon Fried | M | - | - | |
Idan Gal | M | - | - | |
Yair Ayalon | M | - | - | |
Mor Glotter-Nov | F | - | 2 anni | |
Itamar Atzmony | M | 37 | 4 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Sharon Fima | M | 49 | 30 anni | |
Omri Schanin | M | 34 | - | |
Michal Forkosh | F | - | - | |
Eitan Noah | M | - | 2 anni | |
Daniel Ayalon | M | 68 | 2 anni | |
Steven H. Lavin | M | 68 | 2 anni | |
Dan Kozlovski | M | 39 | 5 anni | |
Guy Hefer | M | 42 | 3 anni | |
Lior Maimon | M | - | 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Israele | 22 | 81.48% |
Stati Uniti | 5 | 18.52% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Avraham Hampel
- Contatti personali